Therapeutic Advances for Cystic Fibrosis
Dr. Scott Randell sits down with Dr. Maor Sauler to discuss the biology behind therapeutic advances for the treatment of Cystic Fibrosis. Dr. Randell is an Associate Professor of Medicine at the University of North Carolina School of Medicine and Director of the University of North Carolina Cystic Fibrosis Center Tissue Procurement and Cell Culture Core. In this podcast, Dr. Randell describes CFTR mutation classes and evidence for clinical efficacy of novel therapies for Cystic Fibrosis, as well as new areas of research.
*If you are unable to play the audio please download the file.
